Partial Ban on Perinatal Hepatitis B Vaccination
Parents experiencing childbirth, especially first-time parents, are presented with a barrage of new experiences and information. Medical experts used to be concerned over vaccinating children from age 0-2 due concern that adverse events may be more likely given an infant's small body weight. Studies have shown that low gestational age and low birthweight are useful predictors of risk of autism in vaccinated children. Given that vaccines contain neurotoxins such as aluminum. This makes sense from a toxicological stand point in which body weight determines toxicity. Babies are now being vaccinated on their first or second day of life against Hepatitis B, a disease that is contracted via sharing needles or having sex with an infected person. The CDC's own information on HepB calls for a booster shot - before the time any child is likely to be exposed. Babies born to mothers with HepB infection may be an exception. This indiscriminate use of vaccines shows a lack of regard for the FDA's repeated and consistently stated concerns over the tolerance of individuals to neurotoxins in vaccines. We urge the FDA to (1) analyze the dose exposure to neurotoxins in the first two years of life under the CDC's schedule considering birthweight, (2) to issue a statement reminding the medical community to consider pre-existing conditions for medical exemptions (Criteria C), and (3) to ban unnecessary vaccinations such as HepB thereby protect the infants from unnecessary vaccinations until they achieve a birthweight sufficient to tolerate the doses of vaccines on the CDC pediatric schedule.